RSV Market Shake Up Starts As Sanofi And AZ’s Beyfortus Wins First Approval

With Blockbuster Sales Potential

 
• By Ayisha Sharma
Close up of little baby boy being treated for respiratory problem with vapor nebulizer
More Than 25,000 Children Under Five Died From RSV Infection In 2019 • Source: Shutterstock

More from New Products

More from Scrip